Date:   4/27/2007 11:34:58 PM ( 18 y ago)
Hits:   3,908
URL:   https://www.curezone.org/forums/fm.asp?i=857804

I hope Kebod forgives me but I had to pass on this post she made.

Below is a response concerning the posting on 4/22 by Joseph. This is the position of the American Association of Acupuncture and Oriental Medicine concerning this FDA issue. The letter was sent to me by a friend who is a doctor of oriental medicine.


AAAOM Position
on the
FDA Draft Guidance for CAM Products
April 24, 2007

The FDA has written a document entitled “Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the FDA.” This draft guidance seeks to clarify when a CAM product is subject to regulation under the Federal Food, Drug, and Cosmetic Act (called “the Act”) or the Public Health Service Act (called the “PHS Act”).

The AAAOM has asked several of our expert analysts to review this draft guidance. Based on these reviews, our conclusion is that this document simply reiterates the current regulatory status of CAM products, including herbs. This document contains no new proposed regulations or principles. We see no language that attempts to redefine herbs as drugs or that proposes any new regulation of herbal medicine.

The AAAOM has sent a letter to the FDA acknowledging the draft guidance and alerting them to our desire to be present for any future discussions regarding CAM products. The AAAOM will continue to monitor FDA actions that could impact the practice of acupuncture and Oriental medicine. We encourage our members to read this document and share any concerns with the AAAOM.

Sincerely,


Leslie McGee, RN, LAc, DiplAc
President, American Association of Acupuncture and Oriental Medicine

FDA Docket:


http://www.fda.gov/OHRMS/DOCKETS/98fr/06d-0480-gld0001.pdf



AAAOM Letter to the FDA:


http://www.aaom.info/aaaomresponsefda2006d0480.pdf






 

<< Return to the standard message view

fetched in 0.27 sec, referred by http://www.curezone.org/forums/fmp.asp?i=857804